Home › Asset managers › Compare 2024-2025 › Fidelity vs Lincoln Financial
Fidelity 2024-2025 · Lincoln Financial 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 74,342 | 65,321 | 2,324 | 6,697 | 96.6% | 93.2% |
| Board proposals | 60,945 | 53,132 | 2,069 | 5,744 | 96.3% | 92.7% |
| E&S shareholder proposals | 270 | 135 | 4 | 131 | 97.1% | 85.8% |
| Other items | 13,127 | 12,054 | 251 | 822 | 98.0% | 95.8% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
2,069 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Fidelity | Lincoln Financial |
|---|---|---|---|---|---|---|
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Authorization of the Board to Handle All Related Matters Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Company's Eligibility for Acquisition by Issuance of Shares Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transactions and Validity of the Submitted Legal Documents Regarding This Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Confidentiality Measures and Confidentiality Systems Adopted for This Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Contractual Obligations and Liability for Breach of Contract During Ownership Transfer Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Distribution Arrangement of Undistributed Earnings Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Impact of Dilution of Current Returns on Major Financial Indicators, the Relevant Measures to be Taken Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Purpose and Approach as Well as the Fairness of Pricing Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Issue Amount Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Issue Manner and Target Subscribers Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Listing Exchange Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Lock-Up Period Arrangement Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Price Adjustment Mechanism Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Pricing Basis and Issue Price Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Purchase and Sale of Assets Within the Twelve Months Prior to the Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Relevant Audit Reports, Review Report and Evaluation Report of This Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Report (Draft) and Summary on Company's Acquisition by Issuance of Shares Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Resolution Validity Period Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Signing of Conditional Share Subscription Agreement Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Signing of Supplemental Agreement for Conditional Share Subscription Agreement Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Stock Price Fluctuations Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Transaction Complies with Article 4 of the Guidelines for the Supervision of Listed Companies No. 9 Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Transaction Complies with Articles 11 and 43 of the Measures for the Administration of Major Asset Restructuring of Listed Companies Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Transaction Constitutes as Major Assets Restructuring but not Restructuring for Listing Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Transaction Does Not Constitute as Related-Party Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Transaction Does Not Fall Under the Circumstances Specified in Article 12 of the Guidelines for the Supervision of Listed Companies No. 7 Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Transaction Method and Payment Arrangement Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Transaction Plan Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Transaction Price of Target Assets Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Type and Par Value of Share Issuance Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SERVICE PROPERTIES TRUST | June 13, 2025 | Election of Trustees. Nominees (for Managing Trustee): Adam Portnoy Director Elections |
Board | For | AGAINST 15 funds |
FOR 1 fund |
| SEZZLE INC. | November 19, 2024 | Election of Directors: Paul Paradis Director Elections |
Board | For | FOR 14 funds |
WITHHOLD 1 fund |
| SEZZLE INC. | June 10, 2025 | Election of Directors: Stephen East Director Elections |
Board | For | FOR 16 funds |
WITHHOLD 3 funds |
| SG MICRO CORP. | May 6, 2025 | Approve Authorization of the Board to Handle All Related Matters Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| SG MICRO CORP. | May 6, 2025 | Approve Draft and Summary of Stock Option Incentive Plan Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| SG MICRO CORP. | May 6, 2025 | Approve Methods to Assess the Performance of Plan Participants Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| SG MICRO CORP. | May 23, 2025 | Approve Use of Idle Own Funds for Cash Management Extraordinary Transactions |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SGL CARBON SE | May 21, 2025 | Approve Remuneration Report Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SGL CARBON SE | May 21, 2025 | Elect Georg Denoke to the Supervisory Board Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHAN XI HUA YANG GROUP NEW ENERGY CO. LTD. | January 16, 2025 | Approve Application of Credit Lines Capital Structure |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| SHANDONG GOLD MINING CO. LTD. | November 21, 2024 | Approve Guarantee Provided by the Company for Financing of its Controlling Subsidiary, Cardinal Namdini Mining Limited Capital Structure |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| SHANDONG GOLD MINING CO. LTD. | January 14, 2025 | Approve Estimated Guarantee Amount Provided by Shanjin International (a Controlling Subsidiary of the Company) to its Subsidiaries Capital Structure |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| SHANDONG GOLD MINING CO. LTD. | June 11, 2025 | Approve Guarantee Facility for the Hong Kong Subsidiary Capital Structure |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| SHANDONG HUALU-HENGSHENG CHEMICAL CO. LTD. | April 29, 2025 | Approve Use of Own Funds for Structured Deposits Extraordinary Transactions |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| SHANDONG LINGLONG TYRE CO. LTD. | May 15, 2025 | Approve Credit Line Application and Guarantee Matters Capital Structure |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| SHANDONG SUNPAPER CO. LTD. | December 27, 2024 | Approve Application of Credit Lines Capital Structure |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| SHANDONG SUNPAPER CO. LTD. | December 27, 2024 | Approve Project Financing Through Syndicated Loan Capital Structure |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| SHANDONG SUNPAPER CO. LTD. | December 27, 2024 | Approve Provision of Guarantee Capital Structure |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO. LTD. | June 24, 2025 | Approve Additional Total Credit Applications Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO. LTD. | June 24, 2025 | Approve Grant of General Mandate to Register and Issue Corporate Bonds Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO. LTD. | June 24, 2025 | Approve Renewed and Additional Entrusted Loans/Borrowings Quota Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO. LTD. | June 24, 2025 | Approve Renewed and Additional Guarantee Quota Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI M&G STATIONERY INC. | April 16, 2025 | Approve Remuneration of Supervisors Compensation |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Authorizations Regarding this Issuance to the Executive Committee of the Board Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Face Value and Issuing Price of Bonds to be Issued and Scale of Issuance Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Guarantees Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Interest Rate of Bonds and Its Way of Determination Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Issuance of Debt Financing Products Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Listing Arrangements Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Measures to Guarantee Bonds Repayment Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Method of Issuance Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Method of Principal and Interest Repayment Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Period of Validity of the Resolution Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Satisfaction of Conditions for Issuing Corporate Bonds Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Target of Issuance and Arrangement of Placement to Shareholders of the Company Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Use of Proceeds Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Variety and Term of Bonds Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Way of Underwriting Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHANGHAI PUTAILAI NEW ENERGY TECHNOLOGY CO. LTD. | January 6, 2025 | Approve Provision of Guarantees Capital Structure |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SHANGHAI PUTAILAI NEW ENERGY TECHNOLOGY CO. LTD. | January 6, 2025 | Elect Huang Yong as Director Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| SHANGRI-LA ASIA LTD. | June 12, 2025 | Adopt New 2025 Share Scheme and Scheme Mandate Limit Compensation |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| SHANGRI-LA ASIA LTD. | June 12, 2025 | Adopt Service Provider Sublimit Compensation |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| SHANGRI-LA ASIA LTD. | June 12, 2025 | Amend 2012 Share Award Scheme Compensation |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| SHANGRI-LA ASIA LTD. | June 12, 2025 | Elect Kuok Hui Kwong as Director Director Elections |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| SHANXI LU'AN ENVIRONMENTAL ENERGY DEVELOPMENT CO. LTD. | October 29, 2024 | Approve Financial Assistance Provision Capital Structure |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SHANXI LU'AN ENVIRONMENTAL ENERGY DEVELOPMENT CO. LTD. | May 29, 2025 | Approve Provision of Financial Assistance Capital Structure |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| SHANXI LU'AN ENVIRONMENTAL ENERGY DEVELOPMENT CO. LTD. | May 29, 2025 | Approve Provision of Financial Assistance for Subsidiary Capital Structure |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| SHENG SIONG GROUP LTD. | April 29, 2025 | Approve Issuance of Equity or Equity-Linked Securities with or without Preemptive Rights Capital Structure |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| SHENWAN HONGYUAN GROUP CO. LTD. | December 19, 2024 | Approve Provision of Guarantee for Hongyuan Hengli (Shanghai) Industrial Co., Ltd. Capital Structure |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO. LTD. | May 19, 2025 | Approve Use of Idle Own Funds to Purchase Financial Products Extraordinary Transactions |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SHOPRITE HOLDINGS LTD. | November 11, 2024 | Approve Implementation Report of the Remuneration Policy Compensation |
Board | For | FOR 17 funds |
AGAINST 2 funds |
| SHOPRITE HOLDINGS LTD. | November 11, 2024 | Approve Remuneration Policy Compensation |
Board | For | FOR 17 funds |
AGAINST 2 funds |
| SIA ENGINEERING COMPANY LTD. | July 19, 2024 | Approve Grant of Awards and Issuance of Shares Under the SIAEC Performance Share Plan 2024 Compensation |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| SIA ENGINEERING COMPANY LTD. | July 19, 2024 | Approve Grant of Awards and Issuance of Shares Under the SIAEC Restricted Share Plan 2024 Compensation |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| SICHUAN KELUN PHARMACEUTICAL CO. LTD. | January 15, 2025 | Approve Financing Capital Structure |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| SICHUAN KELUN PHARMACEUTICAL CO. LTD. | May 19, 2025 | Approve Bill Pool Business Capital Structure |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SICHUAN KELUN PHARMACEUTICAL CO. LTD. | May 19, 2025 | Approve Use of Own Funds to Purchase Financial Products Extraordinary Transactions |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| SIEMENS LTD. | February 12, 2025 | Reelect Deepak S. Parekh as Director Director Elections |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SIGMA HEALTHCARE LTD. | January 29, 2025 | Approve Issuance of New Sigma Shares to Chemist Warehouse Shareholders Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| SILVACO GROUP INC. | May 22, 2025 | Election of 9 Director Nominees: Anthony Ngai Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| SILVACO GROUP INC. | May 22, 2025 | Election of 9 Director Nominees: Iliya Pesic Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| SILVACO GROUP INC. | May 22, 2025 | Election of 9 Director Nominees: Katherine Ngai-Pesic Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| SILVERCREST ASSET MANAGEMENT GROUP INC. | June 4, 2025 | To amend our 2012 Equity Incentive Plan, as amended, to increase the authorized number of shares issuable under the plan by 1,500,000 shares. Compensation |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| SIME DARBY BERHAD | November 14, 2024 | Elect Lee Cheow Hock Lawrence as Director Director Elections |
Board | For | FOR 10 funds |
AGAINST 1 fund |
| SIME DARBY BERHAD | November 14, 2024 | Elect Mohamad Idros Mosin as Director Director Elections |
Board | For | FOR 10 funds |
AGAINST 1 fund |
| SIME DARBY BERHAD | November 14, 2024 | Elect Moy Pui Yee as Director Director Elections |
Board | For | FOR 10 funds |
AGAINST 1 fund |
| SIME DARBY BERHAD | November 14, 2024 | Elect Samsudin Osman as Director Director Elections |
Board | For | FOR 10 funds |
AGAINST 1 fund |
| SINGAPORE AIRLINES LTD. | July 29, 2024 | Adopt SIA Performance Share Plan 2024 Compensation |
Board | For | AGAINST 11 funds |
FOR 2 funds |
| SINGAPORE AIRLINES LTD. | July 29, 2024 | Adopt SIA Restricted Share Plan 2024 Compensation |
Board | For | AGAINST 11 funds |
FOR 2 funds |
| SINGAPORE LAND GROUP LTD. | April 29, 2025 | Approve Issuance of Equity or Equity-Linked Securities with or without Preemptive Rights Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
← Previous Page 17 of 21 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.